Back to Find a Doctor
Dr. Alison Gizinski

Dr. Alison M. Gizinski, MD, MS

I am a rheumatologist based at Grady Hospital. I supervise the Grady Rheumatology Fellow’s Clinic and inpatient rheumatology consultations. I have experience in basic science, translational research, clinical trials and a master’s degree in clinical science. I have extensively educated undergraduates, medical students, residents and fellows at the University of Colorado, University of Michigan and the University of Arkansas for Medical Sciences (UAMS). I served as the rheumatology fellowship program director for three years at UAMS. I have a great passion for educating patients and their families about their conditions and for educating physicians in the care of patients with rheumatic disease. My clinical interests include rheumatoid arthritis, connective tissue disease associated lung and eye disease.


  • Rheumatology
  • Internal Medicine

Board Certifications

  • ABMS Internal Medicine


  • University of Colorado


  • Emory

Education & Training

  • Medical School: University of Washington School of Medicine
  • Residency: University of Colorado


Peer-Reviewed Journals and Publications 1.

Gizinski AM, Nelson JL. Maternal HLA Compatibility as a Risk Factor for Systemic Lupus Erythematosus in Males. Journal of Investigative Medicine 1999, 47(2), 74A.

Gizinski AM, Kervitsky D, Meehan R, Brown KK, Holers VM, Deane KD. Rheumatoid Arthritis-Specific Autoantibodies Are Present in Patients with Interstitial Lung Disease in the Absence of Arthritis. Journal of Investigative Medicine 2007, 55(416), S144.

Gizinski AM, Mascolo M, Loucks JL, Kervitsky A, Meehan RT, Brown KK, Holers VM, Deane KD. Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA. Clin Rheumatol. 2009 May; 28(5):611-3. doi: 10.1007/s10067-009-1128-9. Epub 2009 Feb 28. PubMed PMID: 19252818; PubMed Central PMCID: PMC4084723

Fox DA, Gizinski A, Morgan R, Lundy SK. Cell-cell interactions in rheumatoid arthritis synovium. Rheum Dis Clin North Am. 2010 May; 36(2):311-23. doi: 10.1016/j.rdc.2010.02.004. Review. PubMed PMID: 20510236; PubMed Central PMCID: PMC2879397.

Gizinski AM, Fox DA, Sarkar S. Pharmacotherapy: concepts of pathogenesis and emerging treatments. Co-stimulation and T cells as therapeutic targets. Best Pract Res Clin Rheumatol. 2010 Aug; 24(4):463-77. doi: 10.1016/j.berh.2009.12.015. Review. PubMed PMID: 20732645; PubMed Central PMCID: PMC3146352.

Willis VC, Gizinski AM, Banda NK, Causey CP, Knuckley B, Cordova KN, Luo Y, Levitt B, Glogowska M, Chandra P, Kulik L, Robinson WH, Arend WP, Thompson PR, Holers VM. N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen- induced arthritis. J Immunol. 2011 Apr 1; 186(7):4396-404. doi: 10.4049/jimmunol.1001620. Epub 2011 Feb 23. PubMed PMID: 21346230; PubMed Central PMCID: PMC3085980.

Keith RC, Powers JL, Redente EF, Sergew A, Martin RJ, Gizinski A, Holers VM, Sakaguchi S, Riches DW. A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice. Exp Lung Res. 2012 Mar;38(2):55-66. doi: 10.3109/01902148.2011.636139. Epub 2011 Dec 20. PubMed PMID: 22185348.

Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, Friday S, Li S, Patel RM, Subramanian V, Thompson P, Chen P, Fox DA, Pennathur S, Kaplan MJ. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013 Mar 27; 5(178):178ra40. doi: 10.1126/scitranslmed.3005580. PubMed PMID: 23536012; PubMed Central PMCID: PMC3727661.

Gizinski AM, Fox DA. T cell subsets and their role in the pathogenesis of rheumatic disease. Curr Opin Rheumatol. 2014 Mar;26(2):204-10. doi: 10.1097/BOR.0000000000000036. Review. PubMed PMID: 24445478.

Gizinski AM, Fox DA. Emerging Therapeutic Targets; IL-15, IL-17, IL-18 and IL-23. RHEUMATOLOGY, Fifth Edition edited by Marc C. Hochberg, MD, Alan J. Silman, MSC, MD, FRCP, FMEDSCI, Josef S. Smolen, MD, Michael E. Weinblatt, MD, and Michael H. Weisman, MD. 2010. ISBN: 978-0-323-05740-0

Lundy SK, Fox DA, Gizinski A. Introduction to clinical immunology: overview of the immune response, autoimmune conditions, and immunosuppressive therapeutics. In: Nabel EG, editor. ACP Medicine: Allergy & Immunology. Hamilton, ON: Decker Publishing; 2012. p. 1-15.

Gizinski AM, Fox DA. Chapter 65 Emerging therapeutic targets: GM-CSF, IL-17and IL-23. RHEUMATOLOGY, Sixth Edition edited by Marc C. Hochberg, MD MPH, Alan J. Silman, MSC, MD, FRCP, FMEDSCI, Josef S. Smolen, MD, Michael E. Weinblatt, MD, and Michael H. Weisman, MD. July 2014. ISBN: 978-0-323-09138-1

Lundy SK, Fox DA, Gizinski A. Introduction to Clinical Immunology: Overview of the Immune Response, Autoimmune Conditions, and Immunosuppressive Therapeutics for Rheumatic Diseases. Scientific American Medicine. Singh AK, editor. May 2016. ISSN: 2292-597X.